Heparin and related substances for preventing diabetic kidney disease.
Li, Jun; Wu, Hong Mei; Zhang, Ling; Zhu, Bin; Dong, Bi Rong.
Cochrane Database Syst Rev
; (9): CD005631, 2010 Sep 08.
Artigo em Inglês | MEDLINE | ID: mdl-20824845
Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication.
Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
[GOOD PLANNING PRACTICE IN PRECLINICAL AND CLINICAL STUDIES OF UNFRACTIONATED AND FRACTIONATED HEPARINS IN RUSSIA AS THE BASIS OF SAFE AND EFFECTIVE ANTICOAGULATION THERAPY].
Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Anticoagulation for people with cancer and central venous catheters.
Treatment of bleeding complications in patients on anticoagulant therapy.
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.
Clinical Evaluation of Measuring the ACT during Elective Cardiac Surgery with Two Different Devices.
Znamo li sve o ucincima heparina u bolesnika lijecenih hemodijalizom?
Heparin versus placebo for non-ST elevation acute coronary syndromes.